Stephan P Verweij
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Stephan P Verweij has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Sander Ouburg
Department of Medical Microbiology & Infection Control, Laboratory of Immunogenetics, VU University Medical Center, Amsterdam, the Netherlands
7 shared publications - Remco Petrus Peters
Department of Medical Microbiology, University of Pretoria, Pretoria, South Africa
4 shared publications - Servaas Antonie Morré
Institute for Public Health Genomics (IPHG), Department of Genetics and Cell Biology, Research School GROW (School for Oncology & Developmental Biology), Faculty of Health, Medicine & Life Sciences, University of Maastricht, Universiteitssingel 40, 6229 ER Maastricht, The Netherlands
4 shared publications C. J. Bax
Department of Obstetrics and Gynaecology, MC Haaglanden, The Hague, The Netherlands
2 shared publicationsK. D. Quint
DDL Diagnostic Laboratory, Voorburg, The Netherlands
2 shared publicationsP. M. Oostvogel
Department of Medical Microbiology, MC Haaglanden, The Hague, The Netherlands
2 shared publications
Latest Publications
- 1 November 2015
- Published by Elsevier in Microbes and Infection
- Vol. 17 (11-12) , 745-748
Waddlia chondrophila and Chlamydia trachomatis antibodies in screening infertile women for tubal pathology
- 1 November 2015
- Published by Elsevier in Microbes and Infection
- Vol. 17 (11-12) , 745-748
Waddlia chondrophila and Chlamydia trachomatis antibodies in screening infertile women for tubal pathology
- Open Access
- 2 January 2014
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 14 (1) , 3
Serovar D and E of serogroup B induce highest serological responses in urogenital Chlamydia trachomatisinfections
Chlamydia trachomatis is the most prevalent bacterial sexually transmitted infection (STI) worldwide. A strong link between C. trachomatis serogroup/serovar and serological response has been suggested in a previous preliminary study. The aim of the current study was to confirm and strengthen those findings about serological IgG responses in relation to C. trachomatis serogroups and serovars.
- 2 January 2014
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 14 (1) , 3
Open AccessSerovar D and E of serogroup B induce highest serological responses in urogenital Chlamydia trachomatisinfections
Chlamydia trachomatis is the most prevalent bacterial sexually transmitted infection (STI) worldwide. A strong link between C. trachomatis serogroup/serovar and serological response has been suggested in a previous preliminary study. The aim of the current study was to confirm and strengthen those findings about serological IgG responses in relation to C. trachomatis serogroups and serovars.
- 24 April 2013
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 142 (2) , 409-414
Serogroup distribution of urogenital Chlamydia trachomatis in urban ethnic groups in The Netherlands
The prevalence of Chlamydia trachomatis varies between ethnic groups in The Netherlands. It is, however, unknown whether this is associated with specific serogroups. The objective of this study was to determine whether serogroup distribution is associated with ethnic origin in the region of The Hague, The Netherlands. Serogroups of 370 microbiologically confirmed C. trachomatis-positive samples were analysed. The samples were obtained from 247 women and 123 men between January and October 2008, of self-reported Dutch Caucasian, Dutch Antillean, Surinamese, N. African/Turkish or other descent. We observed a difference in serogroup distribution comparing Dutch Caucasian women to Dutch Antillean women (χ2 for distribution P = 0·035). Serogroup C was more common in Dutch Antillean women, whereas serogroup B was less common (P = 0·03). This difference was not observed for Dutch Antillean men. The observed difference in distribution of C. trachomatis serogroups between ethnic groups is relevant for further transmission studies.
- 24 April 2013
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 142 (2) , 409-414
Serogroup distribution of urogenital Chlamydia trachomatis in urban ethnic groups in The Netherlands
The prevalence of Chlamydia trachomatis varies between ethnic groups in The Netherlands. It is, however, unknown whether this is associated with specific serogroups. The objective of this study was to determine whether serogroup distribution is associated with ethnic origin in the region of The Hague, The Netherlands. Serogroups of 370 microbiologically confirmed C. trachomatis-positive samples were analysed. The samples were obtained from 247 women and 123 men between January and October 2008, of self-reported Dutch Caucasian, Dutch Antillean, Surinamese, N. African/Turkish or other descent. We observed a difference in serogroup distribution comparing Dutch Caucasian women to Dutch Antillean women (χ2 for distribution P = 0·035). Serogroup C was more common in Dutch Antillean women, whereas serogroup B was less common (P = 0·03). This difference was not observed for Dutch Antillean men. The observed difference in distribution of C. trachomatis serogroups between ethnic groups is relevant for further transmission studies.
- 22 February 2012
- Published by BMJ in Sexually Transmitted Infections
- Vol. 88 (5) , 346-347
The first case record of a female patient with bubonic lymphogranuloma venereum (LGV), serovariant L2b
Since 2003, a lymphogranuloma venereum epidemic has been reported in The Netherlands and other European countries. This epidemic is caused byChlamydia trachomatisserovariant L2b and has only been seen in men having sex with men. The authors investigated a woman presenting with a bubo in her right groin. The authors showed by real-time PCR that the woman was infected withC trachomatis, serovariant L2b. This is the first reported case study of a female patient with bubonic lymphogranuloma venereum caused by serovariant L2b, which was probably contracted via her bisexual male partner.
- 22 February 2012
- Published by BMJ in Sexually Transmitted Infections
- Vol. 88 (5) , 346-347
The first case record of a female patient with bubonic lymphogranuloma venereum (LGV), serovariant L2b
Since 2003, a lymphogranuloma venereum epidemic has been reported in The Netherlands and other European countries. This epidemic is caused byChlamydia trachomatisserovariant L2b and has only been seen in men having sex with men. The authors investigated a woman presenting with a bubo in her right groin. The authors showed by real-time PCR that the woman was infected withC trachomatis, serovariant L2b. This is the first reported case study of a female patient with bubonic lymphogranuloma venereum caused by serovariant L2b, which was probably contracted via her bisexual male partner.
- 1 November 2011
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 17 (11) , 1727-1730
Lymphogranuloma venereum variant L2b-specific polymerase chain reaction: insertion used to close an epidemiological gap
- 1 November 2011
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 17 (11) , 1727-1730
Lymphogranuloma venereum variant L2b-specific polymerase chain reaction: insertion used to close an epidemiological gap
- Open Access
- 26 July 2011
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 11 (1) , 203
Evaluation of sexual history-based screening of anatomic sites for chlamydia trachomatis and neisseria gonorrhoeae infection in men having sex with men in routine practice
Sexually transmitted infection (STI) screening programmes are implemented in many countries to decrease burden of STI and to improve sexual health. Screening for Chlamydia trachomatis and Neisseria gonorrhoeae has a prominent role in these protocols. Most of the screening programmes concerning men having sex with men (MSM) are based on opportunistic urethral testing. In The Netherlands, a history-based approach is used. The aim of this study is to evaluate the protocol of screening anatomic sites for C. trachomatis and N. gonorrhoeae infection based on sexual history in MSM in routine practice in The Netherlands.
- 26 July 2011
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 11 (1) , 203
Open AccessEvaluation of sexual history-based screening of anatomic sites for chlamydia trachomatis and neisseria gonorrhoeae infection in men having sex with men in routine practice
Sexually transmitted infection (STI) screening programmes are implemented in many countries to decrease burden of STI and to improve sexual health. Screening for Chlamydia trachomatis and Neisseria gonorrhoeae has a prominent role in these protocols. Most of the screening programmes concerning men having sex with men (MSM) are based on opportunistic urethral testing. In The Netherlands, a history-based approach is used. The aim of this study is to evaluate the protocol of screening anatomic sites for C. trachomatis and N. gonorrhoeae infection based on sexual history in MSM in routine practice in The Netherlands.
- 1 November 2009
- Vol. 45, 135-140
SIGNIFICANTLY HIGHER SEROLOGIC RESPONSES OF CHLAMYDIA TRACHOMATIS B GROUP SEROVARS VERSUS C AND I SEROGROUPS
Chlamydia trachomatis serovars ore divided into three serogroups, namely serogroup B, serogroup I (intermediate) and serogroup C, and subsequently into 79 different serovars. Worldwide, serogroup B is the most prevalent followed by serogroup I. Clear differences have been observed in the duration of infection and growth kinetics between serovars from different serogroups in murine and cell culture models. Reasons for these observed differences ore bacterial and host related, and ore not well understood. The aim of this study was to determine the differences in immunoglobulin (Ig) C responses between the three serogroups in a group of patients infected with different serovars. Serovars were assessed from 235 C. trachomatis-positive patients and quantitative IgG responses were determined. Analyses of variance were used to compare the IgG responses between the three serogroups. Of the serovars, 46% were B group (with serovar E the most prevalent: 35.3%), 39.6% were I group and 74.3% were C group. A highly significant difference in serologic response was shown when comparing the mean IgG concentrations (AU/mL) of patients having serovars in the most prevalent serogroup compared to the other serogroups: B = 135, C 46 and I = 60 (B vs. C and B vs. I, P < 0.001). In conclusion, the most prevalent serovars generate the highest serologic responses.
- 1 November 2009
- Vol. 45, 135-140
SIGNIFICANTLY HIGHER SEROLOGIC RESPONSES OF CHLAMYDIA TRACHOMATIS B GROUP SEROVARS VERSUS C AND I SEROGROUPS
Chlamydia trachomatis serovars ore divided into three serogroups, namely serogroup B, serogroup I (intermediate) and serogroup C, and subsequently into 79 different serovars. Worldwide, serogroup B is the most prevalent followed by serogroup I. Clear differences have been observed in the duration of infection and growth kinetics between serovars from different serogroups in murine and cell culture models. Reasons for these observed differences ore bacterial and host related, and ore not well understood. The aim of this study was to determine the differences in immunoglobulin (Ig) C responses between the three serogroups in a group of patients infected with different serovars. Serovars were assessed from 235 C. trachomatis-positive patients and quantitative IgG responses were determined. Analyses of variance were used to compare the IgG responses between the three serogroups. Of the serovars, 46% were B group (with serovar E the most prevalent: 35.3%), 39.6% were I group and 74.3% were C group. A highly significant difference in serologic response was shown when comparing the mean IgG concentrations (AU/mL) of patients having serovars in the most prevalent serogroup compared to the other serogroups: B = 135, C 46 and I = 60 (B vs. C and B vs. I, P < 0.001). In conclusion, the most prevalent serovars generate the highest serologic responses.